Recall Record

Austin, TX, United States

Luminex Corporation recalls

23 recalls recorded since 2018, most recently on 16 April 2025. 14 are listed as ongoing. Status and classification are as published by the FDA.

Recalls23
Ongoing (FDA)14
Terminated or completed9
Class I (FDA)0

Completed Class II Medical devices

Recall started
16 April 2025
Reason
It was determined that the consumable issue may result in No Call - INT CTL 1 and/or False Negative results on a small portion of the lot of test cartridges.
Distribution
US Nationwide distribution in the states of AL, CA, MN, TX, AZ, NJ, WA, SC, VA, GA, VT, CT, MD.
Initiated
Voluntary: Firm initiated
Recall number
Z-1903-2025

Ongoing Class II Medical devices

Recall started
20 June 2024
Reason
Potential for defective test cartridges which may result in false positive results for the Staphylococcus lugdunensis and Enterococcus faecium targets.
Distribution
US Nationwide distribution including in the states of AZ, CA, CO, DE, FL, GA, IA, IL, KY, MD, MI, MN, MO, MS, NE, NV, OH, OK, SC, TN, TX, VA, VT, WA, WV.
Initiated
Voluntary: Firm initiated
Recall number
Z-2533-2024

Ongoing Class II Medical devices

Recall started
7 November 2023
Reason
Potentially defective utility trays in the reagent kits.
Distribution
Worldwide - US Nationwide distribution in the states of AZ, CA, CO, DE, FL, GL, IL, IN, MA, MD, MI, MN, MO, MS, NE, NY, OH, OK, OR, TN, TX, UT, VA, WA, and WI. The country of Italy.
Initiated
Voluntary: Firm initiated
Recall number
Z-0500-2024

Ongoing Class II Medical devices

Recall started
5 June 2023
Reason
It is possible that in rare instances the VERIGENE CDF Nucleic Acid Test Kit (Part No. 20-005-022) and the VERIGENE Enteric Pathogens Nucleic Acid Test Kit (Part No. 20-005-023) could provide a false-negative result due to hydrophobic characteristics in specific FLOQSwab lots.
Distribution
Worldwide and US Nationwide Distribution
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2024-2023, Z-2023-2023

Ongoing Class II Medical devices

Recall started
14 September 2022
Reason
A part defect with the wash 1 syringe of an SARS-CoV-2 assay could lead to incomplete extraction thereby producing an invalid or false negative assay result.
Distribution
Distribution US nationwide, Indonesia, and Hong Kong.
Initiated
Voluntary: Firm initiated
Recall number
Z-0134-2023

Ongoing Class II Medical devices

Recall started
14 July 2022
Reason
SARS-CoV-2 assay that detects SARS-CoV-2 ORF1ab and N genes may not detect the ORF1ab gene. A positive results if either SARS-CoV-2 genes is detected, but If both genes are mistakenly not detected, a false negative result would be generated.
Distribution
U.S. Nationwide distribution in the states of NE, TX, MS, TN, KY, ME, CA.
Initiated
Voluntary: Firm initiated
Recall number
Z-1524-2022

Ongoing Class II Medical devices

Recall started
17 June 2022
Reason
There is a potential for false negative results using VERIGENE CDF Stool PREP KIT and VERIGENE EP Stool PREP KIT due to hydrophobic characteristics of the swab.
Distribution
Worldwide distribution - US Nationwide and the countries of Kuwait, Austria, France, Greece, Kuwait, Turkey.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1335-2022, Z-1334-2022

Ongoing Class II Medical devices

Recall started
5 April 2022
Reason
Heater within the Verigene System may be outside of established temperature limits for assays which could result in false negative results.
Distribution
US:OH, ME, PA, FL, IL, NE, IN, TX, GA, WA, MI, CO, AZ, OH, KY, CA, VT OUS: None
Initiated
Voluntary: Firm initiated
Recall number
Z-1092-2022

Ongoing Class II Medical devices

Recall started
15 February 2022
Reason
Higher than normal "No Call Internal Control failures" due to a missing reagent within a small subset of the extraction tray lot.
Distribution
US
Initiated
Voluntary: Firm initiated
Recall number
Z-1109-2022

Terminated Class II Medical devices

Recall started
17 November 2021
Terminated
8 July 2024
Reason
Impacted lot may leak inside the ARIES instrument. Testing confirmed a leak rate of 0.9%. Leaking cassettes could potentially lead to incorrect results or a delay in reporting results due to an Invalid.
Distribution
Worldwide distribution - US Nationwide distribution in the states of New Jersey, California, Connecticut, Minnesota, Missouri, New Jersey, New Mexico, Pennsylvania, Tennessee, Washington, and Wisconsin) and the country of Malaysia.
Initiated
Voluntary: Firm initiated
Recall number
Z-0553-2022

Ongoing Class II Medical devices

Recall started
3 August 2021
Reason
There is potential for false positive results.
Distribution
Worldwide distribution - US Nationwide distribution and the countries of Austria, France, Greece, Japan, and Turkey.
Initiated
Voluntary: Firm initiated
Recall number
Z-2451-2021

Terminated Class II Medical devices

Recall started
16 April 2021
Terminated
20 September 2024
Reason
Impacted lot may leak inside the ARIES instrument.
Distribution
Worldwide distribution - US Nationwide distribution in the states of Alabama, California, Georgia, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, New Jersey, New Mexico, Ohio, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, Vermont, Virginia, Washington, Wisco
Initiated
Voluntary: Firm initiated
Recall number
Z-0498-2022

Ongoing Class II Medical devices

Recall started
18 March 2021
Reason
Potential for a false-negative result for Vibrio parahaemolyticus, Salmonella, and/or Shigella spp when used with the VERIGENE Enteric Pathogens Nucleic Acid Test Kit.
Distribution
Worldwide distribution - United States (nationwide) and the countries of Austria, France, Greece, Japan, Netherlands, Turkey.
Initiated
Voluntary: Firm initiated
Recall number
Z-1488-2021

Ongoing Class II Medical devices

Recall started
30 October 2020
Reason
Potential for a false-negative result.
Distribution
Worldwide distribution - US Nationwide including in the states of AL, AZ, CA, CO, CT, DE, DC, FL, GA, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, NE, NV, NH, NJ, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA and VT. The countries of Austria, Chile, France, Germany, Greece, Italy, Ja
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2006-2021, Z-2008-2021, Z-2009-2021, Z-2010-2021, Z-2011-2021, Z-2007-2021

Terminated Class II Medical devices

Recall started
13 October 2020
Terminated
22 January 2024
Reason
Luminex has determined that three (3) separate test fixtures used by field service engineers to service the VERIGENE SP Processors were procured from unapproved sources and, in some cases, were manufactured using unvalidated processes. These text fixtures were used to calibrate and verify VERIGENESP devices.
Distribution
Worldwide distribution. US nationwide and Kuwait, Austria, United Kingdom, Spain, France, Chile, Japan, Netherlands, Greece, Italy, Thailand, Germany, Turkey
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0476-2021, Z-0477-2021

Terminated Class II Medical devices

Recall started
15 June 2020
Terminated
30 June 2023
Reason
An instrument failure mode that may result in a Blood Culture Gram Positive (BC-GP) or Gram Negative (BC-GN) false negative call.
Distribution
Worldwide distribution - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CN, CT, DE, DC, FL,GA, ID, IN, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NB, NV, NE, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN TX, UT, VT, VA, WA, WV, WY, and WI. The countri
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2776-2020, Z-2775-2020

Ongoing Class II Medical devices

Recall started
22 April 2019
Reason
Two of three complaints were initiated due to the customers repeatedly obtaining No Call results on the Processor SPs in question.
Distribution
US: TX, CT, LA
Initiated
Voluntary: Firm initiated
Recall number
Z-0920-2022

Ongoing Class II Medical devices

Recall started
20 February 2019
Reason
Through internal investigation, it was discovered that a portion of side cassette assemblies (SCAs) back side seal (BSS) did not meet design specification, resulting in partially sealed SCAs. The impact of a partial seal of the BSS could result in potential decrease of volume for each solution in the SCAs and decreased sensitivity or stability of the assay.
Distribution
US: AK, AL, AZ,CA,CO,FL,GA,IL,KS,KY,LA,MA,MD,ME,MI,MN,MO,MS,MT,NC,NE,NJ,NM,NY,OH,ON,OR,PA,TN,TX,UT,VA,VT,WA,WI, OUS: Belgium, Canada, Thailand, Germany, Singapore, United Kingdom
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2283-2019, Z-2287-2019, Z-2284-2019, Z-2285-2019, Z-2286-2019, Z-2282-2019, Z-2288-2019

Terminated Class III Medical devices

Recall started
26 December 2018
Terminated
4 August 2020
Reason
On lot of VERIGENE(R) BC-GP Utility Kits (20-011-018) were labeled with the VERIGENE(R) Amplification Tray label.
Distribution
Worldwide Distribution: US (nationwide) and countries of: Austria, and Italy.
Initiated
Voluntary: Firm initiated
Recall number
Z-0822-2019

Ongoing Class II Medical devices

Recall started
10 December 2018
Reason
No results/incorrect results due to failure of the hybridization heater.
Distribution
US distribution in MO. No OUS
Initiated
Voluntary: Firm initiated
Recall number
Z-0054-2021

Terminated Class II Medical devices

Recall started
14 September 2018
Terminated
28 April 2021
Reason
Potential to lead to a false negative results.
Distribution
Worldwide Distribution - US Nationwide in the states of United States - AZ, CA, CO, CT, DC, FL, GA,, IA, ID, IN, KA,, KS, KY, LA, MA, MD, MI, MN, MO, MS, NC, ND, NV, NJ, NY, OK,,OH, OR, PA, SC, TN, TX, UT, VT, WA, KS, and VA.. France
Initiated
Voluntary: Firm initiated
Recall number
Z-0445-2019

Terminated Class II Medical devices

Recall started
29 June 2018
Terminated
28 April 2021
Reason
An incorrect control board and firmware installed in some of the Hand Held Barcode Scanners could result in sample/patient mismatch or duplicate results (from other patients specimens) for a patient order.
Distribution
Worldwide distribution. US nationwide, Canada, Ireland, Netherlands, Singapore, Thailand, and United Kingdom
Initiated
Voluntary: Firm initiated
Recall number
Z-2292-2019

Terminated Class II Medical devices

Recall started
8 May 2018
Terminated
29 June 2020
Reason
Elevated false positive results Yersinia enterocolitica (Yersinia) from customers using the EP Nucleic Acid Test Cartridges component (20-006-023) from the Verigene EP Nucleic Acid Test Kit (20-005-023).
Distribution
Domestic Distribution: Arizona, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Kansas, Michigan, Minnesota, Missouri, New Hampshire, Tennessee, Texas, Utah, West Virginia, Wisconsin.
Initiated
Voluntary: Firm initiated
Recall number
Z-2952-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.